1. Home
  2. CASH vs VCYT Comparison

CASH vs VCYT Comparison

Compare CASH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASH
  • VCYT
  • Stock Information
  • Founded
  • CASH 1954
  • VCYT 2006
  • Country
  • CASH United States
  • VCYT United States
  • Employees
  • CASH N/A
  • VCYT 824
  • Industry
  • CASH Major Banks
  • VCYT Medical Specialities
  • Sector
  • CASH Finance
  • VCYT Health Care
  • Exchange
  • CASH Nasdaq
  • VCYT Nasdaq
  • Market Cap
  • CASH 1.9B
  • VCYT 2.4B
  • IPO Year
  • CASH N/A
  • VCYT 2013
  • Fundamental
  • Price
  • CASH $75.30
  • VCYT $30.22
  • Analyst Decision
  • CASH Buy
  • VCYT Buy
  • Analyst Count
  • CASH 2
  • VCYT 9
  • Target Price
  • CASH $91.00
  • VCYT $39.89
  • AVG Volume (30 Days)
  • CASH 190.3K
  • VCYT 2.4M
  • Earning Date
  • CASH 07-28-2025
  • VCYT 08-06-2025
  • Dividend Yield
  • CASH 0.27%
  • VCYT N/A
  • EPS Growth
  • CASH 4.46
  • VCYT N/A
  • EPS
  • CASH 6.92
  • VCYT 0.34
  • Revenue
  • CASH $733,796,000.00
  • VCYT $479,129,000.00
  • Revenue This Year
  • CASH $14.15
  • VCYT $12.57
  • Revenue Next Year
  • CASH $5.99
  • VCYT $10.23
  • P/E Ratio
  • CASH $10.89
  • VCYT $90.02
  • Revenue Growth
  • CASH 5.46
  • VCYT 19.91
  • 52 Week Low
  • CASH $62.79
  • VCYT $22.61
  • 52 Week High
  • CASH $86.00
  • VCYT $47.32
  • Technical
  • Relative Strength Index (RSI)
  • CASH 42.79
  • VCYT 67.14
  • Support Level
  • CASH $71.95
  • VCYT $26.61
  • Resistance Level
  • CASH $77.04
  • VCYT $30.73
  • Average True Range (ATR)
  • CASH 1.97
  • VCYT 1.17
  • MACD
  • CASH 0.07
  • VCYT 0.75
  • Stochastic Oscillator
  • CASH 33.40
  • VCYT 93.47

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Share on Social Networks: